- Home
- XPEL vs OPK Comparison
XPEL vs OPK Comparison
Compare XPEL & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XPEL | OPK |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 921.2M |
| IPO Year | 2019 | 2011 |
Fundamental Metrics
Financial Performance| Metric | XPEL | OPK |
|---|---|---|
| Price | $39.61 | $1.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $2.03 |
| AVG Volume (30 Days) | 227.5K | ★ 2.5M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.12 | N/A |
| EPS | ★ 1.85 | N/A |
| Revenue | $476,200,000.00 | ★ $606,879,000.00 |
| Revenue This Year | $12.64 | N/A |
| Revenue Next Year | $11.98 | $4.24 |
| P/E Ratio | $21.78 | ★ N/A |
| Revenue Growth | ★ 13.27 | N/A |
| 52 Week Low | $24.27 | $1.10 |
| 52 Week High | $55.91 | $1.69 |
Technical Indicators
Market Signals| Indicator | XPEL | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 40.31 | 42.87 |
| Support Level | $35.10 | $1.12 |
| Resistance Level | $55.36 | $1.27 |
| Average True Range (ATR) | 1.37 | 0.04 |
| MACD | 0.63 | 0.00 |
| Stochastic Oscillator | 70.02 | 33.33 |
Price Performance
Historical ComparisonAbout XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services principally to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from Product, which includes Paint protection film and Window film. The company derives revenue from Service, which includes Software, Cutbank credits, and Installation labor. The majority of revenue is derived from the United States.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.